The particular ALS-associated variant of SQSTM1 that we analyzed, identified in a late-onset sporadic ALS patient, is a conservative amino acid change (leucine to valine) which has previously been predicted by web-based prediction tools to represent a benign substitution.18 Here, SQSTM1 is linked to amyotrophic lateral sclerosis.